Antioxidant Potential of a Non-Heme Iron Complex: Mitigating H₂O₂-Induced Cellular Damage

Area of Science:

• Coordination Chemistry
• Catalysis
• Biomedical Applications

Background:

• Iron complexes are explored for antioxidant properties, but functional nonheme iron mimics for hydrogen peroxide (H₂O₂) mitigation are scarce.
• Developing stable and efficient H₂O₂-scavenging catalysts is crucial for medical and general applications.

Purpose of the Study:

• To investigate water-soluble nonheme iron complexes derived from pyridinophanes for H₂O₂ decomposition.
• To evaluate the impact of ligand scaffold modifications on catalytic activity and stability.
• To assess the potential of these complexes as therapeutic antioxidant catalysts in a cellular model.

Main Methods:

• Synthesis and characterization of nonheme iron complexes with pyridinophane ligands (e.g., ^CF₃PyN₃, PyN₃, ^NMe₂PyN₃, Py₂N₂).
• Kinetic and speciation analyses to determine H₂O₂ disproportionation activity.
• Crystallographic characterization of the Fe(Py₂N₂)³⁺ complex.
• In vitro and cellular assays using HeLa cells to evaluate H₂O₂-induced oxidative stress mitigation.

Main Results:

• Ligand scaffold modulation significantly impacts H₂O₂ decomposition activity; electron-donating groups increase rate but decrease stability, while electron-withdrawing groups enhance stability at the cost of rate.
• The unsubstituted Fe(PyN₃)³⁺ complex demonstrated optimal catalytic efficiency (k = 1.45 M⁻¹ s⁻¹) and turnover number (TON = 33) under physiological conditions.
• The Fe(Py₂N₂)³⁺ complex formed a μ-oxo-bridged dimer, explaining its reduced reactivity.
• Fe(PyN₃)³⁺ effectively mitigated H₂O₂-induced oxidative stress in HeLa cells, improving cell viability by reducing reactive oxygen species (ROS).

Conclusions:

• Key design principles for stable, Fenton-resistant nonheme iron catalysts were established.
• Well-defined iron-pyridinophane frameworks can translate homogeneous catalytic activity into biological systems.
• These findings provide a foundation for designing novel therapeutic antioxidant catalysts.